On December 8, 2020 THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, reported that it has obtained a €1.9 million state-guaranteed loan (Prêt Garanti par l’État or PGE) from a bank syndicate (Press release, Theradiag, DEC 8, 2020, View Source [SID1234572435]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The loan is 90% guaranteed by the French government, with an initial maturity of 12 months plus an extension option enabling Theradiag to defer repayment of the principal over a period of up to five years.